Watch: New Cancer Drugs from Artificial Life

In 2014 artificial life was made for the first time.

Two new nucleotides were added—X and Y—to the standard four: A, G, T, C

These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.

Now biotech company Synthorx has announced that they have developed a new cancer drug using these artificial bacteria.

Interleukin-2 has been studied for decades as an immune system-stimulating cancer therapy, but it unfortunately comes with some serious side effects and is often unpredictable.

By adding an extra unnatural amino acid to Interleukin, Synthorx created a “Synthorin” that prolongs the protein’s activity while eliminating its immune-suppressing effects.

So, it turns out that creating artificial life is more than a cool laboratory trick—it may turn out to be a great new way to create new drugs as well.

http://www.sandiegouniontribune.com/business/biotech/sd-me-synthorx-cancer-20180430-story.html

Follow us on social media for the latest updates in B2B!

Image

Latest

TGR Foundation
Tiger Woods’ TGR Foundation Is Reimagining Educational Access Through STEAM, AI, and Community Partnerships
May 19, 2026

As schools across the United States continue grappling with post-pandemic learning loss, declining student engagement, and shrinking emergency funding, nonprofit organizations are increasingly stepping in to fill critical gaps. Recent national studies on literacy recovery, student engagement, and career-connected learning show that educators are facing significant post-pandemic challenges in keeping students connected to pathways that…

Read More
Talent
Higher Ed Must Build a Talent Supply Chain to Fix Workforce Readiness
May 18, 2026

The traditional pathway from college to career is starting to break down—and both universities and employers are feeling the strain. Higher education is under mounting pressure to prove career outcomes as employers question graduate readiness and internships decline. In fact, many institutions are reporting shrinking internship pipelines even as employers continue to prioritize prior…

Read More
healthcare
The Healthcare Talent Fix: Build Pipelines Early, Use Data, and Get the Experience Right
May 18, 2026

There’s a growing tension inside healthcare right now—between the people leaving the workforce and the patients still arriving every day. It’s a dynamic that leaders can no longer afford to ignore. The numbers make that clear: the Association of American Medical Colleges estimates that the U.S. could be short of as many as 86,000 physicians…

Read More
education
Just Thinking… About Federal Funds, Student Support, and the Future of Education with Eric Reaves
May 15, 2026

As conversations around the future of the U.S. Department of Education continue to intensify, educators and federal program leaders are facing mounting uncertainty about how federal funds will be managed, distributed, and regulated. At the same time, schools serving historically underserved students remain heavily reliant on programs like Title I and other federally supported initiatives…

Read More